Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avitec
- Development stage
- Unknown
- Lead developer
- Elanco
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Oral, Inhalation, Ophthalmic
01
Overview
Avitec is a brand of live attenuated poultry vaccines developed for the prevention of major avian viral respiratory diseases, specifically Infectious Bronchitis (IB) and Newcastle Disease (ND). The product line, originally developed by Lohmann Animal Health and now marketed by Elanco, includes several formulations tailored to specific viral strains. **Avitec H120** contains the H120 strain of the Infectious Bronchitis Virus (IBV), a gammacoronavirus that causes significant economic losses due to respiratory distress and decreased egg production. **Avitec ND** utilizes the La Sota strain of the Newcastle Disease Virus (NDV). These vaccines are designed for mass administration in commercial poultry operations via drinking water or coarse spray, inducing rapid mucosal and systemic immunity. By stimulating the host's immune system to recognize and neutralize these pathogens, Avitec helps maintain flock health and prevents secondary bacterial infections.
- Brand names
- AvitecAvitec H120Avitec NDAvitec ND-IB
- Other names
- Infectious Bronchitis VaccineNewcastle Disease Vaccine
Beyond the preview
Go deeper on Avitec.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avitec.